Amy de Haar-Holleman

Author

Kinderkrebs-Zentrum Hamburg ORCID

Also Known As

A Holleman, A. De Haar Holleman, A. Holleman, Amy Holleman, Amy de Haar-Holleman

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Kinderkrebs-Zentrum Hamburg Erasmus MC - Sophia Children’s Hospital St. Jude Children's Research Hospital Erasmus MC Heinrich Heine University Düsseldorf

About

Amy de Haar-Holleman is an author at Kinderkrebs-Zentrum Hamburg specializing in oncology, cancer research, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	268
2	Cell Biology	2	2	268
3	Immunology	1	1	156
4	Cancer Genetics	1	1	112
5	Tumor Biology	1	1	112

Amy de Haar-Holleman

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Gene-Expression Patterns in Drug-Resistant Acute Lymphoblastic Leukemia Cells and Response to Treatment Amy de Haar-Holleman, Meyling Cheok, Monique L. den Boer, New England Journal of Medicine	2004	643
Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells Esther Hulleman, Karin M. Kazemier, Amy de Haar-Holleman, Blood	2008	209
Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia Sanne Lugthart, Meyling Cheok, Monique L. den Boer, Cancer Cell Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaImmunologyTreatment Response	2005	156
The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia Amy de Haar-Holleman Blood	2005	154
miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo Amy de Haar-Holleman, Ivy Chung, Rachelle R. Olsen, Oncogene Mir-135a ContributesTumor BiologyMedicineTumor CellsCancer Biology	2011	112
Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia Amy de Haar-Holleman, Monique L. den Boer, Karin M. Kazemier, Blood	2003	88
Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia Amy de Haar-Holleman, Monique L. den Boer, Karin M. Kazemier, Blood	2005	69
Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocols Amy de Haar-Holleman Blood	2006	25
Chemoradiation for muscle-invasive bladder cancer using 5-fluorouracil versus capecitabine: A nationwide cohort study Amy de Haar-Holleman, Lisa M.C. van Hoogstraten, Maarten C.C.M. Hulshof, Radiotherapy and Oncology	2023	11

Page 1